Found 6 matching trials
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia N/A This clinical trial is a non-interventional, observational, multicenter, po...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1 PHASE2 This investigator-initiated, prospective, single-arm, open-label, single-ce...
Show More Location
Multiple Locations
Learn More & Join Trial
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia PHASE1 This is a single-arm, open-label,phase I clinical study to evaluate the saf...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection N/A This clinical trial adopts an observational research method to conduct annu...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission. PHASE2 Evaluate the safety and efficacy of Inaticabtagene autoleucel combined with...
Show More Location
National Institute of Hematology, Chinese Academy of Medical Sciences
Learn More & Join Trial
Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy PHASE1 This is a multicenter, open-label, single-arm Phase I clinical trial to eva...
Show More Location
Multiple Locations
Learn More & Join Trial